NCT02450799View on ClinicalTrials.gov

Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Pseudophakia
Interventions
DEVICE

Acrylic IOL

Acrylic IOL for long-term implantation in the cataract patient

DEVICE

Silicone IOL

Silicone IOL for long-term implantation in the cataract patient

DEVICE

PMMA IOL

Polymethylmethacrylate IOL for long-term implantation in the cataract patient

All Listed Sponsors
lead

Alcon, a Novartis Company

INDUSTRY

NCT02450799 - Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation | Biotech Hunter | Biotech Hunter